Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Endothelial precursor cell-based therapy to target the pathologic angiogenesis and compensate tumor hypoxia — Guillaume Collet (2015) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Endothelial precursor cell-based therapy to target the pathologic angiogenesis and compensate tumor hypoxia
Shared by
Jozef Dulak
Jagiellonian University Cracow
Endothelial precursor cell-based therapy to target the pathologic angiogenesis and compensate tumor hypoxia
Article
2015
en
Authors
+17 more
GC
Guillaume Collet
KS
Krzysztof Szade
WN
Witold N. Nowak
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2015
Angiogenesis revisited: Endothelial cell metabolism as a target?
Peter Carmeliet
Article
2015
Abstract SY15-04: Angiogenesis revisited: Endothelial cell metabolism as a target
Peter Carmeliet
Article
2014
Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease
Jermaine Goveia
,
Peter C. Stapor
,
Peter Carmeliet
Article
2012
Use of tumor-targeting endothelial precursor cells to carry specific anti-angiogenic decoy
Guillaume Collet
,
Nathalie Lamerant‐Fayel
,
Krzysztof Szade
,
Magdalena Tertil
,
Jacek Stępniewski
,
Alan Guichard
,
Jozef Dulak
,
Claudine Kiéda
Chapter in a book
1998
Lesional Levels of Endothelial Cell Stimulating Angiogenesis Factor (ESAF) and Vascular Endothelial Cell Stimulating Angiogenesis Factor (VEGF) are Elevated in Psoriasis
B. McLaughlin
,
M. Bushan
,
J B Weiss
,
Christopher Em Griffiths
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.